SCHEMBL14015608

SCHEMBL14015608

CN(CCc1ccccc1F)C1CCN(C(=O)C2c3ccccc3Oc3ccccc32)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 5/20 0.47
▸ LMNA P02545 3/20 0.47
▸ NPSR1 Q6W5P4 3/20 0.47
▸ TP53 P04637 1/20 0.47
▸ ALDH1A1 P00352 2/20 0.44
▸ SMN1; SMN2 Q16637 2/20 0.44
▸ TDP1 Q9NUW8 1/20 0.44
▸ MEN1 O00255 3/20 0.44
▸ KMT2A Q03164 3/20 0.44
▸ KDM4E B2RXH2 2/20 0.44
▸ APAF1 O14727 1/20 0.44
▸ HTT P42858 2/20 0.44
▸ MAPK1 P28482 1/20 0.44
▸ TAAR1 Q96RJ0 1/20 0.40
▸ CHRM2 P08172 1/20 0.40
▸ CHRM1 P11229 1/20 0.40
▸ CHRM3 P20309 1/20 0.40
▸ DRD2 P14416 1/20 0.39
▸ DRD4 P21917 1/20 0.39
▸ SSTR1 P30872 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4893799 0.80 TSHR (0.49) TSHRLMNANPSR1TP53ALDH1A1
SCHEMBL3633383 0.79 TSHR (0.61) TSHRLMNANPSR1TP53ALDH1A1
SCHEMBL2404071 0.73 TAAR1 (0.62) ALDH1A1KDM4ETAAR1CHRM2CHRM1
SCHEMBL15127558 0.73 TSHR (0.65) TSHRLMNANPSR1TP53ALDH1A1
SCHEMBL15015186 0.71 CHRM3 (0.40) ALDH1A1MEN1KMT2ATAAR1CHRM2
SCHEMBL8819203 0.70 TSHR (0.71) TSHRLMNANPSR1TP53ALDH1A1
SCHEMBL8820471 0.69 TSHR (0.71) TSHRLMNANPSR1TP53ALDH1A1
SCHEMBL8819880 0.69 TSHR (0.69) TSHRLMNANPSR1TP53ALDH1A1
SCHEMBL9967820 0.67 TSHR (0.54) TSHRLMNANPSR1TP53ALDH1A1
SCHEMBL4886615 0.67 LMNA (0.56) TSHRLMNANPSR1TP53ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2146957-B1 QUATERNARY AMMONIUM COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS THERAVANCE INC (US) 2013-06-12 — — EP disclosed
WO-2008133900-A1 QUATERNARY AMMONIUM COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS THERAVANCE, INC. (US) 2008-11-06 — — WO disclosed
Send feedback